Plasmoblastic leukemia

Acute leukemia or myeloid leukemia is a tumor disease of the blood system, characterized by pathological changes in hematopoietic stem cells and mutations in the cell membrane antigens of lymphocytes or granulocytes. According to histological observations, in acute leukemia there are no lymphocytes, and in connection with this the process is called Aleixid leukemia. Leukemia cells of the granulocytic and monocyte-monoblast type are very sensitive to treatment, so timely initiation of therapy guarantees the patient’s recovery. Chronic leukemia is defined as the self-reproduction and replacement of normal cellular elements in the bone marrow by defective cells arising from the early precursors of granulocytes and red blood cells that have genetic defects in the regulation of division and differentiation, including abnormalities in DNA structure. Depending on the type of differentiation and antigenic properties of tumor cells, polymorphic cell leukemia with the absence of a characteristic formula and chronic myeloid leukemia (granulocytic, non-lymphocytic leukemia) are distinguished.